Development of a Preclinical Candidate for Chagas Disease That Acts Through Inhibition of Trypanosoma Cruzi Squalene Synthase

Project Details

StatusActive
Effective start/end date1/01/2530/06/27

Funding

  • Medical Research Council (APP29949): £3,866,063.29